Study of Olverembatinib (HQP1351) in Patients With CP-CML

Abroad (travel likely)RecruitingPHASE3

Conditions

Chronic Myeloid Leukemia · CML · CML, Chronic Phase

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Second STOP After Pioglitazone Priming in CML Patients

Chronic Myeloid Leukemia (CML)

Abroad (travel likely)RecruitingPHASE2

Le Chesnay, France · Le Kremlin-Bicêtre, France

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

Chronic Myeloid Leukemia (CML)

Abroad (travel likely)RecruitingPHASE2

Bordeaux, France · Lille, France

Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network

Chronic Myeloid Leukemia (CML)

Abroad (travel likely)Recruiting

Monza, Italy

TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients

Chronic Myeloid Leukemia · Accelerated Phase CML

Abroad (travel likely)RecruitingPHASE2

Beijing, China